What is the differential diagnosis for facial lesions in a 67-year-old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis for Facial Lesions in a 67-Year-Old Female

In a 67-year-old woman with facial lesions, the differential diagnosis must prioritize life-threatening malignancies first—particularly melanoma, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC)—followed by benign conditions, as this age group carries significant risk for cutaneous malignancies that directly impact mortality.

Malignant Lesions (Priority Assessment)

Melanoma

The most critical diagnosis to exclude given its mortality implications. Use the ABCDE criteria to assess any pigmented lesion 1:

  • Asymmetry
  • Border irregularity
  • Color heterogeneity
  • Diameter >7mm
  • Evolution (recent change—must coexist with at least one other criterion)

Alternative assessment uses three major change criteria: change in size, color, and shape, plus four minor criteria (diameter >7mm, hypersensitivity, bleeding, inflammation) 1.

Critical action: Dermatoscopy can differentiate melanocytic from non-melanocytic lesions (seborrheic keratosis, pigmented BCC, hemangioma), but should only be used by experienced practitioners 1. Any suspicious pigmented lesion requires complete excision with 2mm margins under local anesthesia for definitive histopathology 1.

Squamous Cell Carcinoma

The second mortality concern, particularly in sun-exposed facial areas. SCC risk increases dramatically in this age group, especially with chronic sun exposure history 2. Look for:

  • Scaly, crusted plaques or nodules
  • Non-healing ulcers
  • Arising from actinic keratoses or Bowen's disease
  • History of prior radiation therapy increases risk 2

Basal Cell Carcinoma

Most common facial malignancy but lowest mortality risk. Presents as pearly papules with telangiectasias, often with central ulceration 1.

Premalignant Lesions

Actinic Keratoses

Sun-induced precancerous lesions that can progress to invasive SCC if untreated 2. Present as rough, scaly patches on sun-damaged skin.

Bowen's Disease

Squamous cell carcinoma in situ, predominantly in older persons, with potential for progression to invasive disease 2.

Inflammatory/Autoimmune Conditions

Lichen Sclerosus (Extragenital)

While uncommon on the face, can present as porcelain-white plaques with follicular dells and ecchymosis. Classical extragenital sites include upper trunk, but face is a recognized rare site 3. Biopsy recommended if atypical features present.

Granulomatous Diseases

Multiple entities present diagnostic challenges on the face 4:

Granuloma Faciale: Reddish plaques or nodules, often clinically misdiagnosed as sarcoidosis, lymphoma, or BCC. Histology shows grenz zone, neutrophils, telangiectases, and vascular changes 5.

Lupus Miliaris Disseminatus Faciei: Monomorphic reddish-brown dome-shaped papules with periorbital predilection, showing granulomatous response around hair follicles with central necrosis 6.

Acneiform/Comedonal Discoid Lupus Erythematosus: Flesh-colored to hyperpigmented dome-shaped papules with scattered comedones and scarring, particularly on cheeks and chin 7.

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome

Multiple bilateral facial nodules in zosteriform pattern, painful with spicy food. Requires fumarate hydratase immunohistochemistry and systemic evaluation for renal/gynecologic malignancies 8.

Infectious Etiologies

Paracoccidioidomycosis

In endemic regions, consider for progressively enlarging erythematous papules evolving to verrucous plaques, especially with systemic symptoms 9.

Algorithmic Approach

  1. First assessment: Any pigmented lesion gets ABCDE evaluation—if positive, excisional biopsy immediately 1

  2. Second assessment: Non-pigmented lesions—evaluate for SCC/BCC features (ulceration, non-healing, pearly appearance). Biopsy any suspicious lesion 2

  3. Third assessment: If inflammatory appearance, consider granulomatous diseases, but never delay biopsy if malignancy cannot be excluded 3

  4. Critical pitfall: Do NOT perform shave, punch, or incisional biopsies of suspected melanoma—complete excisional biopsy only to avoid sampling error and enable accurate Breslow thickness measurement 10. Partial removal creates pseudomelanoma patterns causing diagnostic confusion.

  5. Age-specific consideration: At 67 years, cumulative sun exposure makes all skin cancers more likely. Any changing facial lesion warrants biopsy 11.

The overriding principle: When malignancy cannot be confidently excluded clinically, proceed directly to biopsy rather than observation, as delayed diagnosis of melanoma or SCC directly impacts survival 1, 2, 10.

References

Guideline

cutaneous melanoma.

British Journal of Cancer, 2001

Guideline

basal cell and squamous cell skin cancers.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

[Facial manifestations of granulomatous diseases].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017

Research

Granuloma faciale: a clinicopathologic study of 66 patients.

Journal of the American Academy of Dermatology, 2005

Research

Acneiform lesions in a 57-year-old woman.

International journal of dermatology, 2025

Research

Polymorphic Mucocutaneous Lesions on the Face: A Diagnostic Challenge.

International journal of dermatology, 2026

Research

Problematic lesions in the elderly.

Dermatologic clinics, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.